Erythropoietin and glial cells in central and peripheral nervous systems

被引:0
作者
Haratizadeh, Sara [1 ]
Nemati, Mozhdeh [2 ]
Basiri, Mohsen [3 ]
Nozari, Masoumeh [2 ,3 ]
机构
[1] Mashhad Univ Med Sci, Fac Med, Dept Anat & Cell Biol, Mashhad, Iran
[2] Kerman Univ Med Sci, Afzalipour Sch Med, Dept Physiol & Pharmacol, Kerman, Iran
[3] Kerman Univ Med Sci, Inst Neuropharmacol, Neurosci Res Ctr, Kerman, Iran
关键词
Erythropoietin; Glia cells; Neurodegenerative disease; AQP4; EXPRESSION; SCHWANN-CELLS; DIFFERENTIATION; NEUROGENESIS; MICROGLIA; RECEPTOR; RECOVERY; INJURY; WNT1; EPO;
D O I
10.1007/s11033-024-09997-2
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
Erythropoietin (EPO) is the main hematopoietic growth factor prescribed to overcome anemia. It is also a neuroprotective agent. EPO binds to the erythropoietin receptor (EPOR), expressed on neurons and glial cells in the central nervous system (CNS), and exerts its neuroprotective potencies through the EPO-EPOR complex. The mechanism of the signal transduction pathways of EPO on glial cells is defined. EPO-EPOR complex can affect neurological disorders, such as Alzheimer's disease, Parkinson's disease, ischemia, retinal injury, stroke, hypoxia, trauma, and demyelinating diseases, through acting downstream signaling pathways. This review focuses on the roles of EPO in different types of glial cells (astrocytes, microglia, oligodendrocytes, and Schwann cells) and their relationships with signaling pathways. Information on the non-erythropoietic action of EPO and related signaling systems in connection with glial cells could enhance EPO treatment to restore different CNS disorders and propose new perspectives on the neuroprotective potential of EPO.
引用
收藏
页数:10
相关论文
共 59 条
[1]   Microglia in Neurological Diseases: A Road Map to Brain-Disease Dependent-Inflammatory Response [J].
Bachiller, Sara ;
Jimenez-Ferrer, Itzia ;
Paulus, Agnes ;
Yang, Yiyi ;
Swanberg, Maria ;
Deierborg, Tomas ;
Boza-Serrano, Antonio .
FRONTIERS IN CELLULAR NEUROSCIENCE, 2018, 12
[2]   Schwann cells: Origins and role in axonal maintenance and regeneration [J].
Bhatheja, Kanav ;
Field, Jeffrey .
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY, 2006, 38 (12) :1995-1999
[3]   Evidence that erythropoietin modulates neuroinflammation through differential action on neurons, astrocytes, and microglia [J].
Bond, Wesley S. ;
Rex, Tonia S. .
FRONTIERS IN IMMUNOLOGY, 2014, 5
[4]   Oligodendrocytes: biology and pathology [J].
Bradl, Monika ;
Lassmann, Hans .
ACTA NEUROPATHOLOGICA, 2010, 119 (01) :37-53
[5]   The Recombinant Human Erythropoietin Administered in Neonatal Rats After Excitotoxic Damage Induces Molecular Changes in the Hippocampus [J].
Catalina Rivera-Cervantes, Martha ;
Jaime Jarero-Basulto, Jose ;
Murguia-Castillo, Justo ;
Guadalupe Marin-Lopez, Alejandra ;
Gasca-Martinez, Yadira ;
Comelio-Martinez, Sergio ;
Seas-Zarate, Carlos .
FRONTIERS IN NEUROSCIENCE, 2019, 13
[6]   The role of ERK1/2 in the regulation of proliferation and differentiation of astrocytes in developing brain [J].
Cheng, Peipei ;
Alberts, Ian ;
Li, Xiaohong .
INTERNATIONAL JOURNAL OF DEVELOPMENTAL NEUROSCIENCE, 2013, 31 (08) :783-789
[7]   Erythropoietin protects against hemorrhagic blood-brain barrier disruption through the effects of aquaporin-4 [J].
Chu, Heling ;
Ding, Hongyan ;
Tang, Yuping ;
Dong, Qiang .
LABORATORY INVESTIGATION, 2014, 94 (09) :1042-1053
[8]   Microglia Function in the Central Nervous System During Health and Neurodegeneration [J].
Colonna, Marco ;
Butovsky, Oleg .
ANNUAL REVIEW OF IMMUNOLOGY, VOL 35, 2017, 35 :441-468
[9]   Erythropoietin-loaded solid lipid nanoparticles: Preparation, optimization, and in vivo evaluation [J].
Dara, Tahereh ;
Vatanara, Alireza ;
Meybodi, Mohsen Nabi ;
Vakilinezhad, Molood Alsadat ;
Malvajerd, Soroor Sadegh ;
Vakhshiteh, Faezeh ;
Shamsian, Azam ;
Sharifzadeh, Mohammad ;
Kaghazian, Hooman ;
Mosaddegh, Mohammad Hossein .
COLLOIDS AND SURFACES B-BIOINTERFACES, 2019, 178 :307-316
[10]   Astroglial cytoprotection by erythropoietin pre-conditioning: implications for ischemic and degenerative CNS disorders [J].
Diaz, Z ;
Assaraf, MI ;
Miller, WH ;
Schipper, HM .
JOURNAL OF NEUROCHEMISTRY, 2005, 93 (02) :392-402